Kidney Cancer :: Bayer and Onyx announce pivotal Nexavar kidney cancer study

Bayer Pharmaceuticals Corporation (NYSE: BAY) and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that the New England Journal of Medicine has published their pivotal Phase III trial demonstrating that Nexavar (sorafenib) tablets doubled median progression-free survival (PFS) in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

Heart :: Be true to your heart with a handful of almonds

Are you looking for simple ways to improve your heart health? Including a handful of almonds, whether it?s as a snack or sprinkled throughout your day, may be one easy and satisfying way. Over the past few months, new research on almonds continues to show why including a handful of almonds can help you to be true to your heart. Here?s a look at what they are finding.

Flu :: FDA approves refrigerated form of FluMist

The US Food and Drug Administration (FDA) has approved a refrigerated form of FluMist, the nasal-spray influenza vaccine, which should be more convenient for providers than the current formulation, MedImmune Inc. announced.

Immunity :: Why doesn’t the immune system attack the small intestine?

Answering one of the oldest questions in human physiology, researchers at Dana-Farber Cancer Institute have discovered why the body’s immune system — perpetually on guard against foreign microbes like bacteria — doesn’t attack tissues in the small intestine that harbor millions of bacteria cells.

Weight Gain :: No breakfast and frequent fast food leads to extra pounds in aging teens

The phrase “breakfast is the most important meal of the day” has taken on new meaning for teenagers. A new study suggests that as teens enter adulthood, they are more likely to skip breakfast and increase their fast food consumption, and that both behaviors lead to an increased risk of weight gain. Researchers at the Weight Control and Diabetes Research Center at the Miriam Hospital and Brown Medical School conducted the study.

Diabetes :: Benefits of Diachrome for people with type 2 diabetes

Nutrition 21, Inc., today announced the results of a recent placebo controlled, double-blind, randomized, single center study that demonstrated that Diachrome, a patented combination of chromium picolinate and biotin, safely improves blood glucose levels and cholesterol metabolism in people with type 2 diabetes.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack